Loading...
Human Papillomavirus Prevalence and Vaccination Rates Among Users of Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Prevention
Rotert, Paul Kownack, Jenn Sullivan-Blum, Zoe Cokingtin, Brendan Khetani, Karishma Ndeti, Kavindu Skyes, Kevin Ramaswamy, Megha
Rotert, Paul
Kownack, Jenn
Sullivan-Blum, Zoe
Cokingtin, Brendan
Khetani, Karishma
Ndeti, Kavindu
Skyes, Kevin
Ramaswamy, Megha
Citations
Altmetric:
Genre
Journal article
Date
2022-08-16
Advisor
Committee member
Group
Department
Social and Behavioral Sciences
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1177/21501319221110411
Abstract
Introduction: Our study provides data on the prevalence of human papillomavirus (HPV) related disease and vaccination rates among users of pre-exposure prophylaxis (PrEP) in a primary care clinic. Results highlight an opportunity to partner HIV and HPV prevention efforts. Methods: This is a retrospective chart review of PrEP patients in an urban Midwestern Family Medicine clinic. We conducted univariate analyses for HPV vaccination status and the prevalence of any HPV-related disease. We then examined bivariate relationships between vaccination status and insurance coverage, provider type, and age. Results: Of all 78 PrEP patients identified, 21.8% (n = 17) were vaccinated. Of the 59 patients 45 years or younger, 28.8% (n = 17) were vaccinated. There was no association between insurance or provider type and vaccination status. Patients 26 years or younger were 3 times more likely to be vaccinated than those ages 27 to 45 (56.3% vs 18.6%, P = .0011). Three unvaccinated patients had HPV-related disease. Conclusions: Despite ongoing risk of HPV infection and frequent interaction with the medical system, this study found most PrEP users continue to be unvaccinated. This is a significant missed opportunity for HPV prevention. With the FDA approval of the HPV vaccine for individuals age 9 to 45, PrEP patients in this age range would benefit from clinicians partnering HPV vaccination with PrEP prescribing.
Description
Citation
Rotert P, Wheldon C, Kownack J, et al. Human Papillomavirus Prevalence and Vaccination Rates Among Users of Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Prevention. Journal of Primary Care & Community Health. 2022;13. doi:10.1177/21501319221110411
Citation to related work
SAGE Publications
Has part
Journal of Primary Care & Community Health, Vol. 13
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu